SEHK:9969Biotechs
InnoCare Pharma (SEHK:9969) Climbed, But What Is Driving Attention Now?
How the latest earnings news sets the scene for InnoCare Pharma stock
InnoCare Pharma (SEHK:9969) has just paired a return to profit in its half year 2026 results with fresh guidance that indicates continued profitability and a higher EPS in the second half.
The company reported half year 2026 sales of CNY 1,136.12 million and revenue of CNY 1,137.06 million, alongside net income of CNY 246.36 million instead of a net loss a year earlier.
InnoCare Pharma's half year 2026 earnings and guidance...